The BCR/ABL fusion protein induces IL-6 expression in leukemia stem cells, and targeting IL-6R induces apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia cells (Jiang et al., 2018). Here, BCR is linked to leukemia.